WADA2026
2026 Prohibited List
World Anti-Doping Agency · cited by 14 records
Research / Provenance
Every source, normalized and connected.
51 unique source records show what was cited, where it was used, and which evidence boundary applies.
Preclinical1998
Antimicrobial activity of human cathelicidin LL-37
PubMed · cited by 1 record
FDA2024
AOD-9604 Pharmacy Compounding Advisory Committee briefing
U.S. FDA · cited by 1 record
Review2026
BPC-157 as an investigational peptide therapeutic
PubMed · cited by 1 record
Human trial2019
Bremelanotide for HSDD: two randomized phase 3 trials
PubMed · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
FDA2026
Bulk substances that may present significant safety risks
U.S. FDA · cited by 1 record
Human trial2021
Circulating mitochondrial-derived peptides after exercise
PubMed · cited by 1 record
Government2023
Compounding pharmacy plea involving unlawful unapproved drug distribution
U.S. Department of Justice · cited by 1 record
Government2023
Compounding pharmacy plea involving unlawful unapproved drug distribution
U.S. Department of Justice · cited by 1 record
Review1983
Delta sleep-inducing peptide: human studies review
PubMed · cited by 1 record
Human trial1981
Double-blind crossover study of DSIP in healthy volunteers
PubMed · cited by 1 record
FDA2026
Drugs@FDA database
U.S. FDA · cited by 1 record
FDA2025
EGRIFTA WR prescribing information
U.S. FDA · cited by 1 record
Review2025
Epitalon: structural, physicochemical, and biological research review
PubMed · cited by 1 record
FDA2024
FDA approves first medication for obstructive sleep apnea
U.S. FDA · cited by 1 record
FDA2024–2026
FDA briefing and compounding safety concerns for ipamorelin
U.S. FDA · cited by 1 record
FDA2026
FDA concerns with unapproved GLP-1 drugs used for weight loss
U.S. FDA · cited by 2 records
FDA2025
FDA grants accelerated approval to first treatment for Barth syndrome
U.S. FDA · cited by 1 record
FDA2019
FDA highlights concerns with glutathione in compounded sterile injectables
U.S. FDA · cited by 1 record
FDA2007
FDA report on illegally marketed Melanotan products
U.S. FDA · cited by 1 record
FDA2025
Forzinity prescribing information
U.S. FDA · cited by 1 record
Review2024
Glutathione for skin lightening: systematic review
PubMed · cited by 1 record
Review2025
LL-37 in immunity and disease
PubMed · cited by 1 record
Preclinical2021
MOTS-c and age-dependent physical decline
Nature Communications / PubMed · cited by 1 record
Preclinical2008
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
PubMed · cited by 1 record
FDA2026
Pharmacy Compounding Advisory Committee meeting materials
U.S. FDA · cited by 1 record
Human trial2021
Phase 1 study of recombinant human thymosin beta-4
PubMed · cited by 1 record
Human trial2010
Pooled analysis of two Phase 3 tesamorelin trials
PubMed · cited by 1 record
Human trial2006
Prolonged stimulation of growth hormone and IGF-1 by CJC-1295
PubMed · cited by 1 record
Human trial2011
Randomized trial of oral glutathione supplementation
PubMed · cited by 1 record
Case report2020
Renal infarction associated with Melanotan II use
PubMed · cited by 1 record
Registry2023
Retatrutide Phase 2 obesity study
ClinicalTrials.gov · cited by 1 record
Human trial2008
Selank compared with medazepam in anxiety disorders
PubMed · cited by 1 record
Review2018
Selank pharmacology and research review
PubMed · cited by 1 record
Human trial2018
Semax in acute ischemic stroke
PubMed · cited by 1 record
Human trial2025
Thymosin alpha-1 for sepsis: multicenter randomized phase 3 trial
PubMed · cited by 1 record
Review2025
Thymosin alpha-1 in sepsis: systematic review and meta-analysis
PubMed · cited by 1 record
Review2015
Thymosin beta-4 and tissue repair
PubMed · cited by 1 record
Human trial2015
Thymosin beta-4 ophthalmic solution in dry eye
PubMed · cited by 1 record
Human trial2006
Topical copper tripeptide complex after carbon dioxide laser resurfacing
PubMed · cited by 1 record
Human trial2023
Triple-hormone-receptor agonist retatrutide for obesity — Phase 2
New England Journal of Medicine / PubMed · cited by 1 record
FDA2019
Vyleesi prescribing information
U.S. FDA · cited by 1 record
FDA2026
Wegovy application and labeling record
U.S. FDA · cited by 1 record
FDA2026
Zepbound prescribing information
U.S. FDA · cited by 1 record